Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the ...

Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its research and development investments, including investments done both internally and ...

Key Takeaways Activist investor Starboard Value reportedly has taken a large stake in consumer health care products maker ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

Starboard wants Kenvue, which was spun out of Johnson & Johnson last year and has a market value of over $40 billion, to make ...

The Wall Street Journal reported late Sunday that Starboard Value sees Kenvue as having some of the top consumer brands in its sector, including Tylenol and Listerine, but wants t ...

By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that ...

Investing.com-- Activist investor Starboard Value has taken an around $1 billion stake in Pfizer Inc (NYSE:PFE) and wants the ...

The Wall Street Journal earlier reported the Starboard stake, which it and The Financial Times valued at about $1 billion.

Starboard Value has a sizable stake in Kenvue (KVUE) and wants the company to make changes to boost its share price, Lauren Thomas of Wall ...

Kenvue Inc. (NYSE:KVUE) shares are moving higher Monday following a report suggesting activist investor Starboard Value has ...